Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Randian Biotech is a leading Chinese biotechnology company specializing in high-throughput single-cell sequencing and spatial transcriptomics services. The company provides a comprehensive suite of multi-omics solutions, including single-cell RNA sequencing, single-cell ATAC-seq, and spatial gene expression profiling, to support academic research and pharmaceutical drug discovery. Randian Biotech leverages advanced platforms such as 10x Genomics, BD Rhapsody, and MGI Stereo-seq to deliver high-resolution cellular data for oncology, immunology, and neuroscience. In addition to its research services, the company develops proprietary molecular diagnostic systems and point-of-care testing (POCT) products through its medical technology division. By integrating bioinformatics expertise with cutting-edge laboratory techniques, Randian Biotech assists partners in identifying novel biomarkers and understanding cellular heterogeneity. Headquartered in Shanghai, the company is a key player in the translation of complex genomic data into actionable clinical and research insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 燃点.